DK0666854T3 - Neurobeskyttende 3,4-dihydro-2(1H)-quinolon forbindelser - Google Patents
Neurobeskyttende 3,4-dihydro-2(1H)-quinolon forbindelserInfo
- Publication number
- DK0666854T3 DK0666854T3 DK93918274.7T DK93918274T DK0666854T3 DK 0666854 T3 DK0666854 T3 DK 0666854T3 DK 93918274 T DK93918274 T DK 93918274T DK 0666854 T3 DK0666854 T3 DK 0666854T3
- Authority
- DK
- Denmark
- Prior art keywords
- pct
- fluoro atoms
- compounds
- neuroprotective
- dihydro
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Neurology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Hydrogenated Pyridines (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US96964292A | 1992-10-30 | 1992-10-30 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK0666854T3 true DK0666854T3 (da) | 1997-04-28 |
Family
ID=25515803
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK93918274.7T DK0666854T3 (da) | 1992-10-30 | 1993-07-23 | Neurobeskyttende 3,4-dihydro-2(1H)-quinolon forbindelser |
Country Status (25)
| Country | Link |
|---|---|
| US (1) | US5852040A (ja) |
| EP (1) | EP0666854B1 (ja) |
| JP (1) | JP2695292B2 (ja) |
| KR (1) | KR950704298A (ja) |
| CN (1) | CN1039644C (ja) |
| AT (1) | ATE150751T1 (ja) |
| AU (1) | AU669206B2 (ja) |
| BR (1) | BR9307331A (ja) |
| CA (1) | CA2146260C (ja) |
| CZ (1) | CZ280669B6 (ja) |
| DE (1) | DE69309297T2 (ja) |
| DK (1) | DK0666854T3 (ja) |
| ES (1) | ES2099969T3 (ja) |
| FI (1) | FI934800A (ja) |
| GR (1) | GR3023264T3 (ja) |
| HU (1) | HUT65472A (ja) |
| IL (1) | IL107347A0 (ja) |
| MX (1) | MX9306796A (ja) |
| MY (1) | MY109684A (ja) |
| NO (1) | NO951631D0 (ja) |
| NZ (1) | NZ255074A (ja) |
| PL (1) | PL173618B1 (ja) |
| TW (1) | TW299231B (ja) |
| WO (1) | WO1994010166A1 (ja) |
| ZA (1) | ZA938091B (ja) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ZA9610738B (en) | 1995-12-22 | 1997-06-24 | Warner Lambert Co | Subtype selective nmda receptor ligands and the use thereof |
| ZA9610736B (en) | 1995-12-22 | 1997-06-27 | Warner Lambert Co | 2-Substituted piperidine analogs and their use as subtypeselective nmda receptor antagonists |
| ZA9610741B (en) | 1995-12-22 | 1997-06-24 | Warner Lambert Co | 4-Substituted piperidine analogs and their use as subtype selective nmda receptor antagonists |
| ZA9610745B (en) * | 1995-12-22 | 1997-06-24 | Warner Lambert Co | 4-Subsituted piperidine analogs and their use as subtype selective nmda receptor antagonists |
| US6200990B1 (en) | 1998-12-21 | 2001-03-13 | Alcon Laboratories, Inc. | Neuroprotective agents having antioxidant and NMDA antagonist activity |
| KR20010069066A (ko) * | 2000-01-12 | 2001-07-23 | 이종원 | 저산소 농도하에서 생존이 가능하도록 하는 동물세포의배양방법 |
| US6713490B2 (en) | 2002-04-26 | 2004-03-30 | Pfizer, Inc. | 3,4-dihydroquinolin-2(1H)-one compounds as NR2B receptor antagonists |
| JP2007508288A (ja) * | 2003-10-08 | 2007-04-05 | ファイザー株式会社 | 縮合ラクタム化合物 |
| TWI366565B (en) | 2007-06-06 | 2012-06-21 | Otsuka Pharma Co Ltd | Quinolone compound and pharmaceutical composition |
| CN103664798A (zh) * | 2012-09-20 | 2014-03-26 | 杨育新 | 一类治疗创伤性脑损伤疾病的化合物及其用途 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR5733M (ja) * | 1966-09-27 | 1968-01-22 | ||
| JPS51118772A (en) * | 1975-04-09 | 1976-10-18 | Otsuka Pharmaceut Co Ltd | Method for preparing carbostyryl derivatives |
| FR2534580A1 (fr) * | 1982-10-13 | 1984-04-20 | Synthelabo | Derives de phenyl-1 piperidino-2 propanol, leur preparation, et medicaments qui les contiennent |
| FR2546166B1 (fr) * | 1983-05-19 | 1985-10-25 | Synthelabo | Enantiomeres du erythro (benzyl-4 piperidino)-2 (hydroxy-4 ou benzyloxy-4 phenyl)-1 propanol, leur preparation et leur application en therapeutique |
| EP0322361A3 (de) * | 1987-12-23 | 1990-01-24 | Ciba-Geigy Ag | Weitere hydrierte 1-Benzooxacycloalkylpyridincarbonsäureverbindungen |
| FR2640266B2 (fr) * | 1988-07-12 | 1992-07-10 | Synthelabo | Derives de (hydroxy-1 piperidinyl-2 alkyl) indolones-2, quinoleinones-2, benzo(b)azepinones-2 et benzimidazolones-2, leur preparation et leur application en therapeutique |
| US5506231A (en) * | 1989-03-31 | 1996-04-09 | The Children's Medical Center Corporation | Treatment of aids dementia, myelopathy and blindness |
| EP0398578B1 (en) * | 1989-05-17 | 1997-03-12 | Pfizer Inc. | 2-piperidino-1-alkanol derivatives as antiischemic agents |
| DK0554247T3 (da) * | 1990-05-10 | 2000-08-07 | Pfizer | Neurobeskyttende indolon og beslægtede derivater |
| EP0524846A1 (fr) * | 1991-06-27 | 1993-01-27 | Synthelabo | Dérivés de 2-(pipéridin-1-y1) éthanol, leur préparation et leur application en thérapeutique |
| HUT70528A (en) * | 1991-07-17 | 1995-10-30 | Pfizer | 2-(4-hydroxypiperidino)-1-alkanol derivatives as antiischemic agents and process for production thereof |
| US5498610A (en) * | 1992-11-06 | 1996-03-12 | Pfizer Inc. | Neuroprotective indolone and related derivatives |
-
1993
- 1993-07-23 CZ CZ951110A patent/CZ280669B6/cs unknown
- 1993-07-23 KR KR1019950701695A patent/KR950704298A/ko not_active Application Discontinuation
- 1993-07-23 WO PCT/US1993/006827 patent/WO1994010166A1/en active IP Right Grant
- 1993-07-23 DE DE69309297T patent/DE69309297T2/de not_active Expired - Fee Related
- 1993-07-23 AT AT93918274T patent/ATE150751T1/de not_active IP Right Cessation
- 1993-07-23 CA CA002146260A patent/CA2146260C/en not_active Expired - Fee Related
- 1993-07-23 PL PL93308667A patent/PL173618B1/pl unknown
- 1993-07-23 AU AU47780/93A patent/AU669206B2/en not_active Ceased
- 1993-07-23 DK DK93918274.7T patent/DK0666854T3/da active
- 1993-07-23 ES ES93918274T patent/ES2099969T3/es not_active Expired - Lifetime
- 1993-07-23 JP JP6511033A patent/JP2695292B2/ja not_active Expired - Fee Related
- 1993-07-23 NZ NZ255074A patent/NZ255074A/en unknown
- 1993-07-23 BR BR9307331A patent/BR9307331A/pt not_active Application Discontinuation
- 1993-07-23 EP EP93918274A patent/EP0666854B1/en not_active Expired - Lifetime
- 1993-07-23 US US08/416,804 patent/US5852040A/en not_active Expired - Fee Related
- 1993-07-26 TW TW082105939A patent/TW299231B/zh active
- 1993-10-21 IL IL107347A patent/IL107347A0/xx unknown
- 1993-10-28 MY MYPI93002262A patent/MY109684A/en unknown
- 1993-10-29 ZA ZA938091A patent/ZA938091B/xx unknown
- 1993-10-29 HU HU9303082A patent/HUT65472A/hu unknown
- 1993-10-29 MX MX9306796A patent/MX9306796A/es not_active IP Right Cessation
- 1993-10-29 FI FI934800A patent/FI934800A/fi not_active Application Discontinuation
- 1993-10-29 CN CN93119806A patent/CN1039644C/zh not_active Expired - Fee Related
-
1995
- 1995-04-28 NO NO951631A patent/NO951631D0/no unknown
-
1997
- 1997-04-22 GR GR970400929T patent/GR3023264T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| MX9306796A (es) | 1994-04-29 |
| CN1039644C (zh) | 1998-09-02 |
| FI934800A0 (fi) | 1993-10-29 |
| JP2695292B2 (ja) | 1997-12-24 |
| EP0666854B1 (en) | 1997-03-26 |
| DE69309297T2 (de) | 1997-07-03 |
| MY109684A (en) | 1997-04-30 |
| GR3023264T3 (en) | 1997-07-30 |
| NZ255074A (en) | 1996-10-28 |
| CZ111095A3 (en) | 1995-11-15 |
| ZA938091B (en) | 1995-05-02 |
| CA2146260C (en) | 1998-04-07 |
| ES2099969T3 (es) | 1997-06-01 |
| ATE150751T1 (de) | 1997-04-15 |
| US5852040A (en) | 1998-12-22 |
| PL308667A1 (en) | 1995-08-21 |
| IL107347A0 (en) | 1994-01-25 |
| JPH07508756A (ja) | 1995-09-28 |
| BR9307331A (pt) | 1999-05-25 |
| PL173618B1 (pl) | 1998-04-30 |
| NO951631L (no) | 1995-04-28 |
| AU4778093A (en) | 1994-05-24 |
| HU9303082D0 (en) | 1994-01-28 |
| CA2146260A1 (en) | 1994-05-11 |
| AU669206B2 (en) | 1996-05-30 |
| DE69309297D1 (de) | 1997-04-30 |
| WO1994010166A1 (en) | 1994-05-11 |
| NO951631D0 (no) | 1995-04-28 |
| HUT65472A (en) | 1994-06-28 |
| FI934800A (fi) | 1994-05-01 |
| KR950704298A (ko) | 1995-11-17 |
| CZ280669B6 (cs) | 1996-03-13 |
| CN1095719A (zh) | 1994-11-30 |
| EP0666854A1 (en) | 1995-08-16 |
| TW299231B (ja) | 1997-03-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2395500C2 (ru) | 2,4-пиримидиндиамины, применяемые в лечении неопластических болезней, воспалительных и иммунных расстройств | |
| EG20280A (en) | Process for preparing of fluoroalkoxybenzylamino derivatives of nitrogen containing heterocycles | |
| DK0792268T3 (da) | Hypolipidæmiske benzothiazepiner | |
| ATE279406T1 (de) | Piperidinderivate mit tachykinin-antagonistischer wirkung | |
| ATE149497T1 (de) | Azanorbornanderivate | |
| RU94022743A (ru) | Амидо- или карбамидо-производные, обладающие антигиперхолестериновой активностью, и фармацевтическая композиция на их основе | |
| DK0666854T3 (da) | Neurobeskyttende 3,4-dihydro-2(1H)-quinolon forbindelser | |
| ATE161725T1 (de) | Verwendung von phosphatdiestern zur behandlung von erkrankungen der retina | |
| HUT50325A (en) | Process for producing bisphenylalkyl piperazine derivatives and pharmaceutical compositions comprising same as active ingredient | |
| GR3034226T3 (en) | 4-p-fluorobenzoyl-1-piperidinyl-propoxy-chromen-4-one derivatives, their preparation and their use in the treatment of psychosis and schizophrenia | |
| DE69400702D1 (de) | N-acylpyrrolidine und arzneimittel zur behandlung oder prophylaxe von mit ckk und gastrin in zusammenhang stehenden krankheiten |